Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/RBC+on+Regeneron+Pharma+%28REGN%29%3A%27The+Buying+Opportunity+Many+Have+Been+Looking+For%2C+With+Overdone+DOJ+Downside+On+Top+Of+Recent+Weakness%27/23056071.html for the full story.
